Valuation : Smith & Nephew plc

Market Cap 12.12B 10.45B 9.83B 8.96B 16.85B 1,150B 16.94B 116B 45.25B 585B 45.5B 44.51B 1,940B P/E 2026 *
18.1x
P/E 2027 * 15.2x
Enterprise Value 14.96B 12.9B 12.14B 11.06B 20.79B 1,420B 20.91B 143B 55.85B 722B 56.16B 54.95B 2,395B EV / Sales 2026 *
2.31x
EV / Sales 2027 * 2.15x
Free-Float
96.02%
Yield 2026 *
2.83%
Yield 2027 * 3.04%
1 day+1.13%
1 week-0.46%
Current month+1.13%
1 month-9.53%
3 months-1.34%
6 months-18.67%
Current year-11.35%
1 week 28.75
Extreme 28.75
29.69
1 month 28.71
Extreme 28.71
32.92
Current year 28.56
Extreme 28.555
37.09
1 year 28.56
Extreme 28.555
38.79
3 years 21.52
Extreme 21.525
38.79
5 years 21.52
Extreme 21.525
39
10 years 21.52
Extreme 21.525
52.26
Manager TitleAgeSince
Chief Executive Officer 54 2022-03-31
Director of Finance/CFO 58 2024-03-31
Chief Tech/Sci/R&D Officer 59 2016-07-31
Director TitleAgeSince
Director/Board Member 67 2017-09-30
Director/Board Member 63 2020-10-31
Director/Board Member 64 2021-02-16
Change 5-day change 1-year change 3-year change Capi.($)
+1.18%-0.46% - - 12.11B
-0.73%-2.91%-17.69%+12.84% 124B
+0.71%+0.19%-22.86%+0.52% 12.11B
-1.60%-2.58%+88.09%+135.97% 10.59B
+1.11%+2.67%-51.62%-70.04% 4.16B
-1.07%-8.97%-24.70%+36.73% 2.52B
+0.53%+0.62% - - 2B
-2.15%+1.20%-34.60%-74.12% 1.82B
-0.07%-1.70%-18.18%-21.31% 1.6B
Average -0.30%-2.16%-11.65%+2.94% 19.87B
Weighted average by Cap. -0.58%-1.40%-12.17%+17.02%

Financials

2026 *2027 *
Net sales 6.47B 5.59B 5.25B 4.79B 9B 615B 9.05B 62.11B 24.17B 313B 24.31B 23.78B 1,036B 6.83B 5.89B 5.54B 5.05B 9.49B 648B 9.55B 65.51B 25.5B 330B 25.64B 25.09B 1,093B
Net income 683M 589M 554M 505M 949M 64.82B 955M 6.55B 2.55B 32.97B 2.56B 2.51B 109B 810M 699M 658M 599M 1.13B 76.91B 1.13B 7.77B 3.03B 39.12B 3.04B 2.98B 130B
Net Debt 2.84B 2.45B 2.3B 2.1B 3.95B 270B 3.97B 27.25B 10.6B 137B 10.66B 10.43B 455B 2.56B 2.21B 2.08B 1.89B 3.56B 243B 3.58B 24.55B 9.56B 124B 9.61B 9.4B 410B
Logo Smith & Nephew plc
Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipment. Net sales break down by activity sector as follows: - orthopedic surgery (39.5%): primarily orthopedic implants (hips, knees and shoulders); - sports medicine, arthroscopy and cervicofacial surgery (31.4%): surgery and damaged tissue repair products and instruments, visualization products, etc.; - wound care (29.1%): skin grafts for major burns victims, treatments for leg ulcers, etc. The United States accounts for 53.6% of net sales.
Employees
17,000
Date Price Change Volume
26-09-01 US$29.09 +1.15% 2,161,445
26-08-31 US$28.76 -0.72% 4,304,386
26-08-28 US$28.97 -0.55% 1,488,335
26-08-27 US$29.13 -0.58% 1,106,201
26-08-26 US$29.30 +0.27% 2,378,777
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
14.41USD
Average target price
17.36USD
Spread / Average Target
+20.51%

Quarterly revenue - Rate of surprise